Antibiotic prophylaxis for preventing bacterial endocarditis following dental procedures

被引:15
|
作者
Rutherford, Samantha J. [1 ]
Glenny, Anne-Marie [2 ]
Roberts, Graham [3 ]
Hooper, Lee [4 ]
Worthington, Helen, V [5 ]
机构
[1] NHS Educ Scotland, Scottish Dent Clin Effectiveness Programme, Dundee, Scotland
[2] Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Dent, Manchester, Lancs, England
[3] Kings Coll London, Dent Inst, London, England
[4] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England
[5] Univ Manchester, Fac Biol, Sch Med Sci,Fac Biol Med & Hlth, Div Dent,Cochrane Oral Hlth, Manchester, Lancs, England
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2022年 / 05期
关键词
*Antibiotic Prophylaxis; Case-Control Studies; Dental Care [*adverse effects; Dentistry; Endocarditis; Bacterial [etiology] [mortality] [*prevention & control; Netherlands [epidemiology; Humans; INFECTIVE ENDOCARDITIS; RISK-FACTORS; RECOMMENDATIONS; AMOXICILLIN; BACTEREMIA; CHILDREN; TRENDS; COVER;
D O I
10.1002/14651858.CD003813.pub5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Infective endocarditis is a severe infection arising in the lining of the chambers of the heart. It can be caused by fungi, but most often is caused by bacteria. Many dental procedures cause bacteraemia, which could lead to bacterial endocarditis in a small proportion of people. The incidence of bacterial endocarditis is low, but it has a high mortality rate. Guidelines in many countries have recommended that antibiotics be administered to people at high risk of endocarditis prior to invasive dental procedures. However, guidance by the National Institute for Health and Care Excellence (NICE) in England and Wales states that antibiotic prophylaxis against infective endocarditis is not recommended routinely for people undergoing dental procedures. This is an update of a review that we first conducted in 2004 and last updated in 2013. Objectives Primary objective To determine whether prophylactic antibiotic administration, compared to no antibiotic administration or placebo, before invasive dental procedures in people at risk or at high risk of bacterial endocarditis, influences mortality, serious illness or the incidence of endocarditis. Secondary objectives To determine whether the effect of dental antibiotic prophylaxis differs in people with different cardiac conditions predisposing them to increased risk of endocarditis, and in people undergoing different high risk dental procedures. Harms Had we foundno evidence from randomised controlled trials or cohort studies on whether prophylactic antibiotics affected mortality or serious illness, and we had found evidence from these or case-control studies suggesting that prophylaxis with antibiotics reduced the incidence of endocarditis, then we would also have assessed whether the harms of prophylaxis with single antibiotic doses, such as with penicillin (amoxicillin 2 g or 3 g) before invasive dental procedures, compared with no antibiotic or placebo, equalled the benefits in prevention of endocarditis in people at high risk of this disease. Search methods An information specialist searched four bibliographic databases up to 10 May 2021 and used additional search methods to identify published, unpublished and ongoing studies Selection criteria Due to the low incidence of bacterial endocarditis, we anticipated that few if any trials would be located. For this reason, we included cohort and case-control studies with suitably matched control or comparison groups. The intervention was antibiotic prophylaxis, compared to no antibiotic prophylaxis or placebo, before a dental procedure in people with an increased risk of bacterial endocarditis. Cohort studies would need to follow at-risk individuals and assess outcomes following any invasive dental procedures, grouping participants according to whether or not they had received prophylaxis. Case-control studies would need to match people who had developed endocarditis after undergoing an invasive dental procedure (and who were known to be at increased risk before undergoing the procedure) with those at similar risk who had not developed endocarditis. Our outcomes of interest were mortality or serious adverse events requiring hospital admission; development of endocarditis following any dental procedure in a defined time period; development of endocarditis due to other non-dental causes; any recorded adverse effects of the antibiotics; and the cost of antibiotic provision compared to that of caring for patients who developed endocarditis. Data collection and analysis Two review authors independently screened search records, selected studies for inclusion, assessed the risk of bias in the included study and extracted data from the included study. As an author team, we judged the certainty of the evidence identified for the main comparison and key outcomes using GRADE criteria. We presented the main results in a summary of findings table. Main results Our new search did not find any new studies for inclusion since the last version of the review in 2013. No randomised controlled trials (RCTs), controlled clinical trials (CCTs) or cohort studies were included in the previous versions of the review, but one case-control study met the inclusion criteria. The trial authors collected information on 48 people who had contracted bacterial endocarditis over a specific two-year period and had undergone a medical or dental procedure with an indication for prophylaxis within the past 180 days. These people were matched to a similar group of people who had not contracted bacterial endocarditis. All study participants had undergone an invasive medical or dental procedure. The two groups were compared to establish whether those who had received preventive antibiotics (penicillin) were less likely to have developed endocarditis. The authors found no significant effect of penicillin prophylaxis on the incidence of endocarditis. No data on other outcomes were reported. The level of certainty we have about the evidence is very tow. Authors' conclusions There remains no clear evidence about whether antibiotic prophylaxis is effective or ineffective against bacterial endocarditis in at-risk people who are about to undergo an invasive dental procedure. We cannot determine whether the potential harms and costs of antibiotic administration outweigh any beneficial effect. Ethically, practitioners should discuss the potential benefits and harms of antibiotic prophylaxis with their patients before a decision is made about administration.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] Physician compliance with American Heart Association guidelines for prevention of bacterial endocarditis in dental procedures
    Koyuncu, Banu Ozveri
    Kandemir, Servet
    Sezer, Fatma Bahar
    Gunbay, Tayfun
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2011, 41 (05) : 851 - 858
  • [42] Antibiotic Prophylaxis of Infective Endocarditis
    Martin H. Thornhill
    Mark Dayer
    Peter B. Lockhart
    Bernard Prendergast
    Current Infectious Disease Reports, 2017, 19
  • [43] Antibiotic prophylaxis of endocarditis Reply
    Chambers, John
    Thornhill, Martin
    Shanson, David
    Prendergast, Bernard
    LANCET INFECTIOUS DISEASES, 2016, 16 (07) : 774 - 775
  • [44] The evidence base for the efficacy of antibiotic prophylaxis in dental practice
    Lockhart, Peter B.
    Loven, Bridget
    Brennan, Michael T.
    Fox, Philip C.
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2007, 138 (04) : 458 - 474
  • [45] KNOWLEDGE AND COMPLIANCE OF DENTISTS' AND DENTAL STUDENTS' WITH RESPECT TO RELEVANT GUIDELINES FOR PRESCRIBING ANTIBIOTIC PROPHYLAXIS FOR THE PREVENTION OF INFECTIVE ENDOCARDITIS: A SYSTEMATIC REVIEW
    Cummins, Jessie
    Mccarthy, Michael
    Esterman, Adrian
    Karve, Avanti
    Lee, Andrew
    JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE, 2020, 20 (01)
  • [46] Review of Guidelines for Dental Antibiotic Prophylaxis for Prevention of Endocarditis and Prosthetic Joint Infections and Need for Dental Stewardship
    Goff, Debra A.
    Mangino, Julie E.
    Glassman, Andrew H.
    Goff, Douglas
    Larsen, Peter
    Scheetz, Richard
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (02) : 455 - 462
  • [47] Endocarditis prophylaxis and congenital heart defects in the Norwegian Public Dental Service
    Sivertsen, Tine B.
    Astrom, Anne N.
    Greve, Gottfried
    Assmus, Jorg
    Skeie, Marit S.
    ACTA PAEDIATRICA, 2013, 102 (01) : 29 - 34
  • [48] Infective endocarditis prophylaxis: moving from dental prophylaxis to global prevention?
    Chirouze, C.
    Hoen, B.
    Duval, X.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (09) : 2089 - 2095
  • [49] Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children
    Capitano B.
    Quintiliani R.
    Nightingale C.H.
    Nicolau D.P.
    Paediatric Drugs, 2001, 3 (10): : 703 - 718
  • [50] Dental procedures and infective endocarditis
    Roche, Y
    MEDECINE ET MALADIES INFECTIEUSES, 2002, 32 (11): : 628 - 634